Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_226_библиотеки_им_акад_М_И_Перельмана
.pdf
101
1.
13
-
2018. . -47
2.
2015. 83.
3.
-
2017. 112.
4.
13
-
2016. S. 5-16 -80.
5.
13
-
. 2017. . -24.
6.
-
2013.
7.
[]
2019. 10.
8.
/
2010. 20.
https://t.me/med1917
102
9.
2012. 57.
10.
--
2016. -16.
47.
11.
2019. 68.
12.
2018. S2.
13.
13
-
2006. 7.
14.
2013. 2. 35.
15.
2010. 89.
16.
2015.
60.
17.
https://t.me/med1917
103
2018.
58.
18.
2004. 9.
19.
13
-
2019. 12.
20. -
2010. -2. 113.
21.
2016. 42.
22.
2017.
40.
23. -
-
215218.
https://t.me/med1917
104
24. -
2010. 37.
25.
2017. 56.
26.
2015. 39.
27.
2013. 55.
28.
2015. 20.
29.
- 2013.
87.
30.
//
2016. 51.
31.
2015. 96.
https://t.me/med1917
105
32. -
2017.
33.
2013.
. 131.
34.
2020. 66.
35.
2016. 57.
36. -
2018. 52.
37.
2019. 2228.
38.
2018. - -23.
39.
- 2-
. 1980. - - - -22.
https://t.me/med1917
106
40.
2016.
4348.
41.
2013.
1-3. 65.
42.
2014. 22.
43. -
-
2008. 52.
44.
2009. 34.
45.
2009.
48.
46.
2018. 14.
47.
2016.
C. 885892.
https://t.me/med1917
107
48.
-
2015. 41.
49.
2015. 18.
50.
2017. 65.
51.
2014.
52.
//
2014. 087.
53.
2019. 39.
54. -
Statistica -
55.
56.
2017. 21.
https://t.me/med1917
108
57.
.
2014. -
23.
58.
2017. 58.
59.
2018. 67.
60.
2015.
40.
61.
[
2017. 35.
62. -
13
-
2014. 11.
63. -
- 3-
--. . , 2011. 318 .
64.
13
C-galactose breath test: correlation with liver fibrosis in chronic hepatitis
C / F. Mion, M. Rousseau, J. Y. Scoazec [et al.] // European journal of clinical
investigation. 1999. P. 624629.
https://t.me/med1917
109
65.
13
C-methacetin breath test for evaluation of liver damage / K. Matsumoto,
M. Suehiro, M. Iio [et al.] // Digestive diseases and sciences. 1987.
P. 344348.
66.
13
C-methacetin breath test for monitoring hepatic function in cirrhotic
patients before and after liver transplantation / A. Petrolati, D. Festi, G. D. Berardinis
[et al.] // Alimentary pharmacology & therapeutics. 2003. P. 785
790.
67.
13
C-methacetin breath test for monitoring hepatic function in cirrhotic
patients before and after liver transplantation / M. Candelli, A. Armuzzi, E. C. Nista [et
al.] // Alimentary pharmacology & therapeutics. 2004. P. 243.
68.
13
C-methacetin breath test in the evaluation of disease severity in patients
with liver cirrhosis / J. Vranova, M. Hendrichova, H. Kolarova [et al.] // Biomedical
papers of the Medical Faculty of the University Palack, Olomouc, Czechoslovakia.
2013. P. 392400.
69.
13
C-methacetin breath test. Text : electronic // Kibion : website. 2015.
December. Br-115-03. 2 p. URL: https://kibion.se/content/uploads/2015/12/Br-
115-03-Methacetin.pdf (date of request: 17.03.2019).
70.
13
CO
2
breath tests in non-invasive hepatological diagnosis / J. Musialik, K.
Jonderko, A. Kasicka-Jonderko, M. Buschhaus // Przeglad gastroenterologiczny.
2015. P. 16.
71.
13
C-phenylalanine and
13
C-methacetin breath test to evaluate functional
capacity of hepatocyte in chronic liver disease / S. L. Baruque, M. Razquin, I. Jimenez
[et al.] // Digestive and liver disease. 2000. P. 226232.
72. A 21-year experience with major hemorrhage after percutaneous liver
biopsy / D. B. McGill, J. Rakela, A. R. Zinsmeister, B. J. Ott // Gastroenterology.
1990. P. 13961400.
73. Accuracy of the enhanced liver fibrosis test vs FibroTest, elastography, and
indirect markers in detection of advanced fibrosis in patients with alcoholic liver disease
https://t.me/med1917
110
/ M. Thiele, B. S. Madsen, J. F. Hansen [et al.] // Gastroenterology. 2018. Vol. 154,
P. 13691379.
74. Adams, L. A. Non-alcoholic fatty liver perhaps not so benign / L. A.
Adams, V. Ratziu // Journal of hepatology. 2015. Vol. 62, 5. P. 10021004.
75. Asian-Pacific Association for the Study of the Liver (APASL) consensus
guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update
/ G. Shiha, A. Ibrahim, A. Helmy [et al.] // Hepatology international. 2017. Vol. 11,
P. 130.
76. Association between diabetes, family history of diabetes, and risk of
nonalcoholic steatohepatitis and fibrosis / R. Loomba, M. Abraham, A. Unalp [et al.] //
Hepatology. 2012. P. 943951.
77. Bedossa, P. An algorithm for the grading of activity in chronic hepatitis C.
The METAVIR Cooperative Study Group / P. Bedossa, T. Poynard // Hepatology.
1996. P. 289293.
78. Bleeding complications after percutaneous liver biopsy: do subcapsular
lesions pose a higher risk? / T. A. Potretzke, L. J. Saling, W. D. Middleton, K. A.
Robinson // AJR. American journal of roentgenology. 2018. P.
204210.
79. Blum, H. E. History and global burden of viral hepatitis / H. E. Blum //
Digestive diseases. 2016. P. 293302.
80. Borkham-Kamphorst, E. The PDGF system and its antagonists in liver
fibrosis / E. Borkham-Kamphorst, R. Weiskirchen // Cytokine and growth factor
reviews. 2016. Vol. 28. P. 5361.
81. Brown, C. R. Addressing the increasing global burden of viral hepatitis / C.
R. Brown, J. H. MacLachlan, B. C. Cowie // Hepatobiliary surgery and nutrition.
2017. P. 274276.
82. Burden of liver disease in Europe: Epidemiology and analysis of risk
factors to identify prevention policies / L. Pimpin, H. Cortez-Pinto, F. Negro [et al.] //
Journal of hepatology. 2018. Vol. 69, 3. P. 718735.
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана